Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Citius Oncology, Inc. (CTOR) had Pre-Tax Income of $-5.11M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-5.37M |
|
-- |
|
-- |
|
$4.95M |
|
$-4.95M |
|
$-0.16M |
|
|
Pre-Tax Income |
$-5.11M |
$-5.11M |
|
$-5.37M |
|
$-5.37M |
|
$-5.37M |
|
$-5.37M |
|
$-4.95M |
|
$-4.95M |
|
71.55M |
|
71.55M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$18.31M |
|
-- |
|
$73.40M |
|
$91.71M |
|
$52.99M |
|
$3.80M |
|
$6.32M |
|
$59.31M |
|
$32.40M |
|
$32.40M |
|
$32.40M |
|
71.55M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
-- |
|
$6.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.35 |
|
-- |
|
-- |
|
0.10 |
|
0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.57% |
|
-16.57% |
|
-5.86% |
|
-14.83% |
|
$0.45 |
|
-- |
|
-- |
|